Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S.

Am J Geriatr Psychiatry. 2009 Feb;17(2):166-9. doi: 10.1097/JGP.0b013e318187de18.

2.

A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study.

Sleep. 2003 Nov 1;26(7):893-901.

3.

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group.

Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9.

PMID:
16286437
4.

Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.

Mintzer JE, Tune LE, Breder CD, Swanink R, Marcus RN, McQuade RD, Forbes A.

Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31.

PMID:
17974864
5.

Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.

Bourne RS, Mills GH, Minelli C.

Crit Care. 2008;12(2):R52. doi: 10.1186/cc6871. Epub 2008 Apr 18.

6.

Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.

Riemersma-van der Lek RF, Swaab DF, Twisk J, Hol EM, Hoogendijk WJ, Van Someren EJ.

JAMA. 2008 Jun 11;299(22):2642-55. doi: 10.1001/jama.299.22.2642.

PMID:
18544724
7.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
8.

The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS).

Appleton RE, Jones AP, Gamble C, Williamson PR, Wiggs L, Montgomery P, Sutcliffe A, Barker C, Gringras P.

Health Technol Assess. 2012;16(40):i-239. doi: 10.3310/hta16400.

9.

Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease.

Dowling GA, Burr RL, Van Someren EJ, Hubbard EM, Luxenberg JS, Mastick J, Cooper BA.

J Am Geriatr Soc. 2008 Feb;56(2):239-46. Epub 2007 Dec 7.

10.

Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.

11.

A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.

Serfaty MA, Osborne D, Buszewicz MJ, Blizard R, Raven PW.

Int Clin Psychopharmacol. 2010 May;25(3):132-42. doi: 10.1097/YIC.0b013e32832c260b.

PMID:
20195158
14.

Effect of melatonin in selected populations of sleep-disturbed patients.

Brusco LI, Fainstein I, Márquez M, Cardinali DP.

Biol Signals Recept. 1999 Jan-Apr;8(1-2):126-31.

PMID:
10085474
15.

Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent.

Wyatt JK, Dijk DJ, Ritz-de Cecco A, Ronda JM, Czeisler CA.

Sleep. 2006 May;29(5):609-18.

PMID:
16774150
16.

Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review.

de Jonghe A, Korevaar JC, van Munster BC, de Rooij SE.

Int J Geriatr Psychiatry. 2010 Dec;25(12):1201-8. doi: 10.1002/gps.2454. Review.

PMID:
21086534
17.

Antidepressant action of melatonin in the treatment of Delayed Sleep Phase Syndrome.

Rahman SA, Kayumov L, Shapiro CM.

Sleep Med. 2010 Feb;11(2):131-6. doi: 10.1016/j.sleep.2009.07.013. Epub 2009 Dec 30.

PMID:
20044310
18.

Effect of melatonin administration on subjective sleep quality in chronic obstructive pulmonary disease.

Nunes DM, Mota RM, Machado MO, Pereira ED, Bruin VM, Bruin PF.

Braz J Med Biol Res. 2008 Oct;41(10):926-31.

19.

Melatonin in patients with reduced REM sleep duration: two randomized controlled trials.

Kunz D, Mahlberg R, Müller C, Tilmann A, Bes F.

J Clin Endocrinol Metab. 2004 Jan;89(1):128-34.

PMID:
14715839
20.

Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilities.

Figueiro MG, Plitnick BA, Lok A, Jones GE, Higgins P, Hornick TR, Rea MS.

Clin Interv Aging. 2014 Sep 12;9:1527-37. doi: 10.2147/CIA.S68557. eCollection 2014.

Items per page

Supplemental Content

Write to the Help Desk